S

Stem Cells Spin SA
WSE:SCS

Watchlist Manager
Stem Cells Spin SA
WSE:SCS
Watchlist
Price: 0.418 PLN -1.42% Market Closed
Market Cap: 17.3m PLN

Net Margin
Stem Cells Spin SA

-623.5%
Current
-240%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-623.5%
=
Net Income
-516.9k
/
Revenue
82.9k

Net Margin Across Competitors

No Stocks Found

Stem Cells Spin SA
Glance View

Market Cap
17.3m PLN
Industry
Biotechnology

Stem Cells Spin SA engages in the development, manufacturing, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets. The company is headquartered in Wroclaw, Woj. Dolnoslaskie. The company went IPO on 2011-10-25. The company is primarily engaged in biotechnology research. The firm is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

SCS Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-623.5%
=
Net Income
-516.9k
/
Revenue
82.9k
What is the Net Margin of Stem Cells Spin SA?

Based on Stem Cells Spin SA's most recent financial statements, the company has Net Margin of -623.5%.

Back to Top